Balancing between care and control: Staff perception on the introduction of long-acting injectables for opioid agonist treatment
Background:Several previous studies have analyzed patient experiences of long-acting injectable buprenorphine (LAIB) in treating opioid use disorder (OUD). This treatment approach reduces the need for daily supervised clinic visits, but also fundamentally changes the dynamic of the relationship between patients and staff. The perspective of staff working with opioid agonist treatment (OAT) on LAIB
